Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 6/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | GBA1 | P04062 | 1/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546933 | 1.00 | L3MBTL1 (0.64) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL10052388 | 0.95 | L3MBTL1 (0.64) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL19034963 | 0.92 | L3MBTL1 (0.55) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL10128397 | 0.92 | L3MBTL1 (0.55) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL19037208 | 0.92 | L3MBTL1 (0.55) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL4546929 | 0.92 | RAB9A (0.59) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL16016367 | 0.91 | L3MBTL1 (0.59) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL18267898 | 0.91 | L3MBTL1 (0.59) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL13700789 | 0.91 | L3MBTL1 (0.59) | L3MBTL1MEN1KMT2AMAPTHPGD | |
| SCHEMBL15690759 | 0.90 | KMT2A (0.55) | L3MBTL1MEN1KMT2AMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10008675-B2 | Organic compound and organic electroluminescent element comprising same | DOOSAN CORPORATION (KR) | 2018-06-26 | — | — | US | disclosed |
| US-9780310-B2 | Heterocyclic compound for organic electroluminescent device and its application | TOSOH CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20170186968-A1 | NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20160351825-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2016-12-01 | — | — | US | disclosed |
| WO-2015008866-A1 | TRIAZINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING SAME | 東ソー株式会社 (JP) | 2015-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160351825-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OR10J3, ORAI2, ETV6 | L3MBTL1 948/4885MEN1 2331/4885KMT2A 1517/4885 |
| US-10008675-B2 | Organic compound and organic electroluminescent element comprising same | OR10J3, ORAI2, ETV6 | L3MBTL1 948/4885MEN1 2331/4885KMT2A 1517/4885 |
| US-20170186968-A1 | NOVEL COMPOUND | SREBF1, BRIX1, SREBF2 | L3MBTL1 2694/4885MEN1 2873/4885KMT2A 3156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.